Sign in
CompletedPhase 4

Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary TKA

Key facts

Who runs it
University of Louisville
Where
Louisville, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 4
People taking part
150 people enrolled
Started
19 Feb 2024
Ended
18 Oct 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Preoperative Methadone
  • Preoperative Oxycodone
Record updated
15 November 2024

Who can take part

Age
21 years to 89 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Patient age is 21-89 at time of surgery
  • Patient is scheduled to undergo a unilateral primary TKA, secondary to osteoarthritis
  • Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document
  • Patient is able to read and speak English

Who cannot take part

  • History of liver or kidney disease,
  • Hypersensitivity to methadone
  • Patient is under the age of 21
  • Patient's primary diagnosis is not osteoarthritis
  • Patient is unable to read and speak English
  • Known or suspected GI obstruction
  • Patients with significant respiratory depression
  • Pregnant or nursing females

Where in United States

  • UofL HealthLouisville, United States

About the trial

What the trial wants to find out

The goal of this prospective, randomized study is to compare the outcomes of two cohorts of patients undergoing primary Total Knee Arthroplasty (TKA) and to determine whether a single dose of methadone administered preoperatively is effective at reducing postoperative opioid usage and postoperative pain versus a control group of patients receiving standard intraoperative opioids only for primary TKA.

Read full original descriptionShow less

The main questions it aims to answer are:

* What is the efficacy of a single preoperative dose of methadone in reducing opioid consumption and postoperative pain in primary total knee arthroplasty? * Will the study results demonstrate the effectiveness and safety of a single preoperative dose of methadone (10 mg) in primary total knee arthroplasty in reducing postoperative opioid usage while maintaining a similar or better level of pain control when compared to a standard pain control regimen? Researchers will compare Methadone to a standard pain control regimen (Oxycodone) to see if Methadone is equivalent or more effective at reducing opioid consumption and postoperative pain in primary total knee arthroplasty

Participants will:

* be randomized into one of two groups * undergo a primary TKA * complete a tracking sheet documenting daily pain medicine usage and VAS pain level for the first 14 days following the TKA * return to office at 2 weeks and 6 weeks postop for follow-up * complete additional questionnaires at 2 weeks and 6 weeks postop

The 2 groups in the trial

  • Methadone GroupTreatment being tested

    Participant receives a one-time preoperative dose of 10 mg of methadone

    Treatment: Preoperative Methadone

  • Oxycodone GroupExisting treatment, for comparison

    participant receives a one-time preoperative dose of 10 mg of oral oxycodone

    Treatment: Preoperative Oxycodone

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary Total Knee Arthroplasty, a Prospective, Randomized Study
Record updated
15 November 2024